TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87 October 10, 1986
TCL Archive AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed December 8, 1978
TCL Archive FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer September 27, 2013
TCL Archive In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman September 2, 1988
TCL Archive NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015 February 14, 2003
